nodes	percent_of_prediction	percent_of_DWPC	metapath
Dihydroxyaluminium—Salivation—Physostigmine—glaucoma	0.0641	0.0721	CcSEcCtD
Dihydroxyaluminium—Salivation—Carbachol—glaucoma	0.0272	0.0306	CcSEcCtD
Dihydroxyaluminium—Electrolyte imbalance—Diclofenamide—glaucoma	0.0259	0.0291	CcSEcCtD
Dihydroxyaluminium—Salivary hypersecretion—Physostigmine—glaucoma	0.0241	0.0271	CcSEcCtD
Dihydroxyaluminium—Electrolyte imbalance—Methazolamide—glaucoma	0.0238	0.0268	CcSEcCtD
Dihydroxyaluminium—VDAC2—eye—glaucoma	0.0221	0.2	CbGeAlD
Dihydroxyaluminium—VDAC2—connective tissue—glaucoma	0.0213	0.192	CbGeAlD
Dihydroxyaluminium—Venous thrombosis—Carbachol—glaucoma	0.0196	0.022	CcSEcCtD
Dihydroxyaluminium—VDAC3—eye—glaucoma	0.0184	0.166	CbGeAlD
Dihydroxyaluminium—VDAC1—eye—glaucoma	0.0175	0.158	CbGeAlD
Dihydroxyaluminium—Fluid overload—Carbachol—glaucoma	0.017	0.0191	CcSEcCtD
Dihydroxyaluminium—VDAC1—connective tissue—glaucoma	0.0169	0.152	CbGeAlD
Dihydroxyaluminium—Electrolyte imbalance—Acetazolamide—glaucoma	0.0165	0.0186	CcSEcCtD
Dihydroxyaluminium—Salivation—Pilocarpine—glaucoma	0.0154	0.0173	CcSEcCtD
Dihydroxyaluminium—TNNC1—connective tissue—glaucoma	0.0145	0.131	CbGeAlD
Dihydroxyaluminium—Extravasation—Carbachol—glaucoma	0.0121	0.0136	CcSEcCtD
Dihydroxyaluminium—Salivation—Betaxolol—glaucoma	0.0107	0.012	CcSEcCtD
Dihydroxyaluminium—Salivary hypersecretion—Carbachol—glaucoma	0.0103	0.0115	CcSEcCtD
Dihydroxyaluminium—Convulsion—Physostigmine—glaucoma	0.00941	0.0106	CcSEcCtD
Dihydroxyaluminium—Phlebitis—Carbachol—glaucoma	0.00889	0.01	CcSEcCtD
Dihydroxyaluminium—Visual disturbance—Carteolol—glaucoma	0.00843	0.00948	CcSEcCtD
Dihydroxyaluminium—Polyuria—Methazolamide—glaucoma	0.00823	0.00926	CcSEcCtD
Dihydroxyaluminium—Visual disturbance—Levobunolol—glaucoma	0.00796	0.00895	CcSEcCtD
Dihydroxyaluminium—Hyponatraemia—Carbachol—glaucoma	0.00769	0.00865	CcSEcCtD
Dihydroxyaluminium—Acidosis—Betaxolol—glaucoma	0.0075	0.00843	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Dipivefrin—glaucoma	0.00736	0.00827	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Echothiophate—glaucoma	0.00729	0.0082	CcSEcCtD
Dihydroxyaluminium—Angina pectoris—Metipranolol—glaucoma	0.00726	0.00816	CcSEcCtD
Dihydroxyaluminium—Pain—Dipivefrin—glaucoma	0.00645	0.00725	CcSEcCtD
Dihydroxyaluminium—Coma—Brimonidine—glaucoma	0.00605	0.0068	CcSEcCtD
Dihydroxyaluminium—Rhinitis—Metipranolol—glaucoma	0.00598	0.00672	CcSEcCtD
Dihydroxyaluminium—Angina pectoris—Latanoprost—glaucoma	0.00589	0.00662	CcSEcCtD
Dihydroxyaluminium—Salivary hypersecretion—Pilocarpine—glaucoma	0.0058	0.00652	CcSEcCtD
Dihydroxyaluminium—Visual impairment—Metipranolol—glaucoma	0.00575	0.00646	CcSEcCtD
Dihydroxyaluminium—Visual disturbance—Bimatoprost—glaucoma	0.00572	0.00644	CcSEcCtD
Dihydroxyaluminium—Polyuria—Acetazolamide—glaucoma	0.0057	0.00641	CcSEcCtD
Dihydroxyaluminium—Vomiting—Physostigmine—glaucoma	0.00564	0.00634	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Dipivefrin—glaucoma	0.00555	0.00624	CcSEcCtD
Dihydroxyaluminium—Pain—Echothiophate—glaucoma	0.0054	0.00607	CcSEcCtD
Dihydroxyaluminium—Visual impairment—Carteolol—glaucoma	0.00532	0.00599	CcSEcCtD
Dihydroxyaluminium—Nausea—Physostigmine—glaucoma	0.00527	0.00592	CcSEcCtD
Dihydroxyaluminium—Thirst—Acetazolamide—glaucoma	0.00526	0.00591	CcSEcCtD
Dihydroxyaluminium—Visual disturbance—Brimonidine—glaucoma	0.00507	0.0057	CcSEcCtD
Dihydroxyaluminium—Visual impairment—Levobunolol—glaucoma	0.00503	0.00566	CcSEcCtD
Dihydroxyaluminium—Hyponatraemia—Acetazolamide—glaucoma	0.00502	0.00565	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Metipranolol—glaucoma	0.00489	0.0055	CcSEcCtD
Dihydroxyaluminium—Visual disturbance—Dorzolamide—glaucoma	0.00484	0.00544	CcSEcCtD
Dihydroxyaluminium—Visual disturbance—Brinzolamide—glaucoma	0.00476	0.00535	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Carteolol—glaucoma	0.00453	0.0051	CcSEcCtD
Dihydroxyaluminium—Oedema—Metipranolol—glaucoma	0.00424	0.00476	CcSEcCtD
Dihydroxyaluminium—Back pain—Latanoprost—glaucoma	0.00408	0.00458	CcSEcCtD
Dihydroxyaluminium—Salivary hypersecretion—Betaxolol—glaucoma	0.00403	0.00453	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Latanoprost—glaucoma	0.00397	0.00447	CcSEcCtD
Dihydroxyaluminium—Oedema—Carteolol—glaucoma	0.00392	0.00441	CcSEcCtD
Dihydroxyaluminium—Vertigo—Methazolamide—glaucoma	0.00391	0.0044	CcSEcCtD
Dihydroxyaluminium—Rhinitis—Apraclonidine—glaucoma	0.00388	0.00436	CcSEcCtD
Dihydroxyaluminium—Angina pectoris—Dorzolamide—glaucoma	0.00386	0.00434	CcSEcCtD
Dihydroxyaluminium—Angina pectoris—Travoprost—glaucoma	0.00384	0.00432	CcSEcCtD
Dihydroxyaluminium—Angina pectoris—Brinzolamide—glaucoma	0.0038	0.00427	CcSEcCtD
Dihydroxyaluminium—Convulsion—Methazolamide—glaucoma	0.00377	0.00424	CcSEcCtD
Dihydroxyaluminium—Rhinitis—Bimatoprost—glaucoma	0.00376	0.00423	CcSEcCtD
Dihydroxyaluminium—Infection—Carbachol—glaucoma	0.00374	0.00421	CcSEcCtD
Dihydroxyaluminium—Visual impairment—Apraclonidine—glaucoma	0.00373	0.00419	CcSEcCtD
Dihydroxyaluminium—Hypotension—Carteolol—glaucoma	0.00367	0.00412	CcSEcCtD
Dihydroxyaluminium—Angina pectoris—Pilocarpine—glaucoma	0.00365	0.0041	CcSEcCtD
Dihydroxyaluminium—Thirst—Clonidine—glaucoma	0.00364	0.00409	CcSEcCtD
Dihydroxyaluminium—Visual impairment—Bimatoprost—glaucoma	0.00362	0.00407	CcSEcCtD
Dihydroxyaluminium—Hypotension—Carbachol—glaucoma	0.00352	0.00396	CcSEcCtD
Dihydroxyaluminium—Thrombophlebitis—Betaxolol—glaucoma	0.00348	0.00391	CcSEcCtD
Dihydroxyaluminium—Hypotension—Levobunolol—glaucoma	0.00347	0.0039	CcSEcCtD
Dihydroxyaluminium—Oedema—Latanoprost—glaucoma	0.00344	0.00387	CcSEcCtD
Dihydroxyaluminium—Rhinitis—Brimonidine—glaucoma	0.00333	0.00375	CcSEcCtD
Dihydroxyaluminium—Urinary retention—Clonidine—glaucoma	0.00329	0.0037	CcSEcCtD
Dihydroxyaluminium—Pain—Carbachol—glaucoma	0.00322	0.00362	CcSEcCtD
Dihydroxyaluminium—Visual impairment—Brimonidine—glaucoma	0.0032	0.0036	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Apraclonidine—glaucoma	0.00317	0.00357	CcSEcCtD
Dihydroxyaluminium—Pain—Levobunolol—glaucoma	0.00317	0.00357	CcSEcCtD
Dihydroxyaluminium—Rhinitis—Travoprost—glaucoma	0.00317	0.00356	CcSEcCtD
Dihydroxyaluminium—Thirst—Betaxolol—glaucoma	0.00317	0.00356	CcSEcCtD
Dihydroxyaluminium—Rhinitis—Brinzolamide—glaucoma	0.00313	0.00352	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Metipranolol—glaucoma	0.00312	0.00351	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Bimatoprost—glaucoma	0.00308	0.00346	CcSEcCtD
Dihydroxyaluminium—Visual impairment—Dorzolamide—glaucoma	0.00306	0.00344	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Diclofenamide—glaucoma	0.00305	0.00343	CcSEcCtD
Dihydroxyaluminium—Visual impairment—Travoprost—glaucoma	0.00304	0.00342	CcSEcCtD
Dihydroxyaluminium—Visual impairment—Brinzolamide—glaucoma	0.00301	0.00338	CcSEcCtD
Dihydroxyaluminium—Rhinitis—Pilocarpine—glaucoma	0.00301	0.00338	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Carbachol—glaucoma	0.00298	0.00335	CcSEcCtD
Dihydroxyaluminium—Urticaria—Levobunolol—glaucoma	0.00295	0.00331	CcSEcCtD
Dihydroxyaluminium—Pain—Latanoprost—glaucoma	0.00294	0.00331	CcSEcCtD
Dihydroxyaluminium—Vertigo—Bimatoprost—glaucoma	0.00293	0.0033	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Carteolol—glaucoma	0.00289	0.00325	CcSEcCtD
Dihydroxyaluminium—Visual impairment—Pilocarpine—glaucoma	0.00289	0.00325	CcSEcCtD
Dihydroxyaluminium—Urticaria—Methazolamide—glaucoma	0.00282	0.00317	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Methazolamide—glaucoma	0.00281	0.00316	CcSEcCtD
Dihydroxyaluminium—Dizziness—Metipranolol—glaucoma	0.0028	0.00315	CcSEcCtD
Dihydroxyaluminium—Oedema—Apraclonidine—glaucoma	0.00275	0.00309	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Levobunolol—glaucoma	0.00273	0.00307	CcSEcCtD
Dihydroxyaluminium—Infection—Apraclonidine—glaucoma	0.00273	0.00307	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Brimonidine—glaucoma	0.00273	0.00306	CcSEcCtD
Dihydroxyaluminium—Chills—Pilocarpine—glaucoma	0.00269	0.00302	CcSEcCtD
Dihydroxyaluminium—Back pain—Dorzolamide—glaucoma	0.00267	0.003	CcSEcCtD
Dihydroxyaluminium—Back pain—Travoprost—glaucoma	0.00266	0.00299	CcSEcCtD
Dihydroxyaluminium—Infection—Bimatoprost—glaucoma	0.00265	0.00298	CcSEcCtD
Dihydroxyaluminium—Back pain—Brinzolamide—glaucoma	0.00263	0.00295	CcSEcCtD
Dihydroxyaluminium—Convulsion—Acetazolamide—glaucoma	0.00261	0.00294	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Dorzolamide—glaucoma	0.0026	0.00293	CcSEcCtD
Dihydroxyaluminium—Visual disturbance—Timolol—glaucoma	0.0026	0.00292	CcSEcCtD
Dihydroxyaluminium—Dizziness—Carteolol—glaucoma	0.0026	0.00292	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Travoprost—glaucoma	0.00259	0.00291	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Carbachol—glaucoma	0.00258	0.0029	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Brinzolamide—glaucoma	0.00256	0.00288	CcSEcCtD
Dihydroxyaluminium—Dizziness—Diclofenamide—glaucoma	0.00255	0.00287	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Levobunolol—glaucoma	0.00254	0.00285	CcSEcCtD
Dihydroxyaluminium—Angina pectoris—Betaxolol—glaucoma	0.00254	0.00285	CcSEcCtD
Dihydroxyaluminium—Back pain—Pilocarpine—glaucoma	0.00252	0.00284	CcSEcCtD
Dihydroxyaluminium—Nausea—Metipranolol—glaucoma	0.00252	0.00283	CcSEcCtD
Dihydroxyaluminium—Dizziness—Carbachol—glaucoma	0.00249	0.0028	CcSEcCtD
Dihydroxyaluminium—Vertigo—Dorzolamide—glaucoma	0.00248	0.00279	CcSEcCtD
Dihydroxyaluminium—Vertigo—Travoprost—glaucoma	0.00247	0.00278	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Pilocarpine—glaucoma	0.00246	0.00277	CcSEcCtD
Dihydroxyaluminium—Vomiting—Diclofenamide—glaucoma	0.00245	0.00276	CcSEcCtD
Dihydroxyaluminium—Dizziness—Levobunolol—glaucoma	0.00245	0.00276	CcSEcCtD
Dihydroxyaluminium—Vertigo—Brinzolamide—glaucoma	0.00244	0.00274	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Methazolamide—glaucoma	0.00243	0.00273	CcSEcCtD
Dihydroxyaluminium—Rhinitis—Clonidine—glaucoma	0.0024	0.0027	CcSEcCtD
Dihydroxyaluminium—Vomiting—Carbachol—glaucoma	0.00239	0.00269	CcSEcCtD
Dihydroxyaluminium—Oedema—Brimonidine—glaucoma	0.00236	0.00265	CcSEcCtD
Dihydroxyaluminium—Pain—Apraclonidine—glaucoma	0.00235	0.00264	CcSEcCtD
Dihydroxyaluminium—Infection—Brimonidine—glaucoma	0.00234	0.00264	CcSEcCtD
Dihydroxyaluminium—Nausea—Carteolol—glaucoma	0.00233	0.00262	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Brimonidine—glaucoma	0.0023	0.00259	CcSEcCtD
Dihydroxyaluminium—Nausea—Diclofenamide—glaucoma	0.00229	0.00258	CcSEcCtD
Dihydroxyaluminium—Pain—Bimatoprost—glaucoma	0.00228	0.00256	CcSEcCtD
Dihydroxyaluminium—Dizziness—Latanoprost—glaucoma	0.00227	0.00256	CcSEcCtD
Dihydroxyaluminium—Vomiting—Methazolamide—glaucoma	0.00226	0.00254	CcSEcCtD
Dihydroxyaluminium—Oedema—Dorzolamide—glaucoma	0.00225	0.00253	CcSEcCtD
Dihydroxyaluminium—Oedema—Travoprost—glaucoma	0.00224	0.00252	CcSEcCtD
Dihydroxyaluminium—Nausea—Carbachol—glaucoma	0.00224	0.00252	CcSEcCtD
Dihydroxyaluminium—Infection—Travoprost—glaucoma	0.00223	0.00251	CcSEcCtD
Dihydroxyaluminium—Hypotension—Brimonidine—glaucoma	0.00221	0.00248	CcSEcCtD
Dihydroxyaluminium—Nausea—Levobunolol—glaucoma	0.0022	0.00248	CcSEcCtD
Dihydroxyaluminium—Infection—Brinzolamide—glaucoma	0.0022	0.00248	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Travoprost—glaucoma	0.00219	0.00246	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Brinzolamide—glaucoma	0.00216	0.00243	CcSEcCtD
Dihydroxyaluminium—Oedema—Pilocarpine—glaucoma	0.00213	0.0024	CcSEcCtD
Dihydroxyaluminium—Infection—Pilocarpine—glaucoma	0.00212	0.00238	CcSEcCtD
Dihydroxyaluminium—Nausea—Methazolamide—glaucoma	0.00211	0.00237	CcSEcCtD
Dihydroxyaluminium—Hypotension—Dorzolamide—glaucoma	0.00211	0.00237	CcSEcCtD
Dihydroxyaluminium—Hypotension—Travoprost—glaucoma	0.0021	0.00236	CcSEcCtD
Dihydroxyaluminium—Rhinitis—Betaxolol—glaucoma	0.00209	0.00235	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Pilocarpine—glaucoma	0.00208	0.00234	CcSEcCtD
Dihydroxyaluminium—Angina pectoris—Timolol—glaucoma	0.00207	0.00233	CcSEcCtD
Dihydroxyaluminium—Hypotension—Brinzolamide—glaucoma	0.00207	0.00233	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Apraclonidine—glaucoma	0.00203	0.00228	CcSEcCtD
Dihydroxyaluminium—Pain—Brimonidine—glaucoma	0.00202	0.00227	CcSEcCtD
Dihydroxyaluminium—Visual impairment—Betaxolol—glaucoma	0.00201	0.00226	CcSEcCtD
Dihydroxyaluminium—Hypotension—Pilocarpine—glaucoma	0.00199	0.00224	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Clonidine—glaucoma	0.00196	0.00221	CcSEcCtD
Dihydroxyaluminium—Urticaria—Acetazolamide—glaucoma	0.00195	0.0022	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Acetazolamide—glaucoma	0.00194	0.00219	CcSEcCtD
Dihydroxyaluminium—Pain—Dorzolamide—glaucoma	0.00193	0.00217	CcSEcCtD
Dihydroxyaluminium—Pain—Travoprost—glaucoma	0.00192	0.00216	CcSEcCtD
Dihydroxyaluminium—Pain—Brinzolamide—glaucoma	0.0019	0.00213	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Apraclonidine—glaucoma	0.00188	0.00212	CcSEcCtD
Dihydroxyaluminium—Chills—Betaxolol—glaucoma	0.00187	0.0021	CcSEcCtD
Dihydroxyaluminium—Pain—Pilocarpine—glaucoma	0.00182	0.00205	CcSEcCtD
Dihydroxyaluminium—Dizziness—Apraclonidine—glaucoma	0.00182	0.00204	CcSEcCtD
Dihydroxyaluminium—Urticaria—Dorzolamide—glaucoma	0.00179	0.00201	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Dorzolamide—glaucoma	0.00178	0.002	CcSEcCtD
Dihydroxyaluminium—Dizziness—Bimatoprost—glaucoma	0.00176	0.00198	CcSEcCtD
Dihydroxyaluminium—Urticaria—Brinzolamide—glaucoma	0.00176	0.00198	CcSEcCtD
Dihydroxyaluminium—Vomiting—Apraclonidine—glaucoma	0.00175	0.00197	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Brimonidine—glaucoma	0.00174	0.00196	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Betaxolol—glaucoma	0.00171	0.00192	CcSEcCtD
Dihydroxyaluminium—Rhinitis—Timolol—glaucoma	0.00171	0.00192	CcSEcCtD
Dihydroxyaluminium—Oedema—Clonidine—glaucoma	0.0017	0.00191	CcSEcCtD
Dihydroxyaluminium—Infection—Clonidine—glaucoma	0.00169	0.0019	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Pilocarpine—glaucoma	0.00168	0.00189	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Acetazolamide—glaucoma	0.00168	0.00189	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Dorzolamide—glaucoma	0.00166	0.00187	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Clonidine—glaucoma	0.00166	0.00187	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Travoprost—glaucoma	0.00165	0.00186	CcSEcCtD
Dihydroxyaluminium—Visual impairment—Timolol—glaucoma	0.00164	0.00185	CcSEcCtD
Dihydroxyaluminium—Nausea—Apraclonidine—glaucoma	0.00163	0.00184	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Brinzolamide—glaucoma	0.00163	0.00184	CcSEcCtD
Dihydroxyaluminium—Vertigo—Betaxolol—glaucoma	0.00163	0.00183	CcSEcCtD
Dihydroxyaluminium—Dizziness—Acetazolamide—glaucoma	0.00163	0.00183	CcSEcCtD
Dihydroxyaluminium—Hypotension—Clonidine—glaucoma	0.00159	0.00179	CcSEcCtD
Dihydroxyaluminium—Nausea—Bimatoprost—glaucoma	0.00158	0.00178	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Pilocarpine—glaucoma	0.00157	0.00176	CcSEcCtD
Dihydroxyaluminium—Vomiting—Acetazolamide—glaucoma	0.00156	0.00176	CcSEcCtD
Dihydroxyaluminium—Dizziness—Brimonidine—glaucoma	0.00156	0.00176	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Dorzolamide—glaucoma	0.00154	0.00173	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Travoprost—glaucoma	0.00154	0.00173	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Brinzolamide—glaucoma	0.00152	0.00171	CcSEcCtD
Dihydroxyaluminium—Dizziness—Dorzolamide—glaucoma	0.00149	0.00168	CcSEcCtD
Dihydroxyaluminium—Dizziness—Travoprost—glaucoma	0.00148	0.00167	CcSEcCtD
Dihydroxyaluminium—Oedema—Betaxolol—glaucoma	0.00148	0.00167	CcSEcCtD
Dihydroxyaluminium—Infection—Betaxolol—glaucoma	0.00147	0.00165	CcSEcCtD
Dihydroxyaluminium—Dizziness—Brinzolamide—glaucoma	0.00147	0.00165	CcSEcCtD
Dihydroxyaluminium—Nausea—Acetazolamide—glaucoma	0.00146	0.00164	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Pilocarpine—glaucoma	0.00146	0.00164	CcSEcCtD
Dihydroxyaluminium—Pain—Clonidine—glaucoma	0.00145	0.00164	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Betaxolol—glaucoma	0.00145	0.00163	CcSEcCtD
Dihydroxyaluminium—Vomiting—Dorzolamide—glaucoma	0.00143	0.00161	CcSEcCtD
Dihydroxyaluminium—Vomiting—Brinzolamide—glaucoma	0.00141	0.00158	CcSEcCtD
Dihydroxyaluminium—Dizziness—Pilocarpine—glaucoma	0.00141	0.00158	CcSEcCtD
Dihydroxyaluminium—Nausea—Brimonidine—glaucoma	0.0014	0.00158	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Timolol—glaucoma	0.0014	0.00157	CcSEcCtD
Dihydroxyaluminium—Hypotension—Betaxolol—glaucoma	0.00138	0.00156	CcSEcCtD
Dihydroxyaluminium—Vomiting—Pilocarpine—glaucoma	0.00135	0.00152	CcSEcCtD
Dihydroxyaluminium—Urticaria—Clonidine—glaucoma	0.00135	0.00152	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Clonidine—glaucoma	0.00134	0.00151	CcSEcCtD
Dihydroxyaluminium—Nausea—Dorzolamide—glaucoma	0.00134	0.00151	CcSEcCtD
Dihydroxyaluminium—Nausea—Travoprost—glaucoma	0.00133	0.0015	CcSEcCtD
Dihydroxyaluminium—Vertigo—Timolol—glaucoma	0.00133	0.0015	CcSEcCtD
Dihydroxyaluminium—Nausea—Brinzolamide—glaucoma	0.00132	0.00148	CcSEcCtD
Dihydroxyaluminium—Pain—Betaxolol—glaucoma	0.00127	0.00142	CcSEcCtD
Dihydroxyaluminium—Nausea—Pilocarpine—glaucoma	0.00127	0.00142	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Clonidine—glaucoma	0.00125	0.00141	CcSEcCtD
Dihydroxyaluminium—Oedema—Timolol—glaucoma	0.00121	0.00136	CcSEcCtD
Dihydroxyaluminium—Infection—Timolol—glaucoma	0.0012	0.00135	CcSEcCtD
Dihydroxyaluminium—Urticaria—Betaxolol—glaucoma	0.00118	0.00132	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Betaxolol—glaucoma	0.00117	0.00132	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Clonidine—glaucoma	0.00116	0.00131	CcSEcCtD
Dihydroxyaluminium—Hypotension—Timolol—glaucoma	0.00113	0.00127	CcSEcCtD
Dihydroxyaluminium—Dizziness—Clonidine—glaucoma	0.00112	0.00126	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Betaxolol—glaucoma	0.00109	0.00123	CcSEcCtD
Dihydroxyaluminium—Vomiting—Clonidine—glaucoma	0.00108	0.00122	CcSEcCtD
Dihydroxyaluminium—Pain—Timolol—glaucoma	0.00103	0.00116	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Betaxolol—glaucoma	0.00101	0.00114	CcSEcCtD
Dihydroxyaluminium—Nausea—Clonidine—glaucoma	0.00101	0.00114	CcSEcCtD
Dihydroxyaluminium—Dizziness—Betaxolol—glaucoma	0.000979	0.0011	CcSEcCtD
Dihydroxyaluminium—Urticaria—Timolol—glaucoma	0.000961	0.00108	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Timolol—glaucoma	0.000956	0.00108	CcSEcCtD
Dihydroxyaluminium—Vomiting—Betaxolol—glaucoma	0.000942	0.00106	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Timolol—glaucoma	0.000891	0.001	CcSEcCtD
Dihydroxyaluminium—Nausea—Betaxolol—glaucoma	0.00088	0.000989	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Timolol—glaucoma	0.000828	0.000931	CcSEcCtD
Dihydroxyaluminium—Dizziness—Timolol—glaucoma	0.0008	0.0009	CcSEcCtD
Dihydroxyaluminium—Vomiting—Timolol—glaucoma	0.000769	0.000865	CcSEcCtD
Dihydroxyaluminium—Nausea—Timolol—glaucoma	0.000719	0.000808	CcSEcCtD
